YOUNG AGE UNDER 60 YEARS IS NOT A CONTRAINDICATION TO TREATMENT WITH DEFINITIVE DOSE ESCALATED RADIOTHERAPY FOR PROSTATE CANCER

BACKGROUND: It is widely believed that younger prostate cancer patients are at greater risk of recurrence following radiotherapy (RT). METHODS: From 1992–2007, 2168 (395 age ≤60) men received conformal RT alone for prostate cancer at our institution (median dose = 76 Gy, range:72–80). Multivariable...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Klayton, Tracy L., Ruth, Karen, Horwitz, Eric M., Uzzo, Robert G., Kutikov, Alexander, Chen, David Y.T., Sobczak, Mark, Buyyounouski, Mark K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225561/
https://ncbi.nlm.nih.gov/pubmed/21889222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2011.07.022
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak